# Growth-Associated Protein-43 Loss Promotes Ca2+ and ROS Imbalance in Cardiomyocytes

**Authors:** Michele Bevere, Caterina Morabito, Delia Verucci, Noemi Di Sinno, Maria A. Mariggiò, Simone Guarnieri

PMC · DOI: 10.3390/antiox14030361 · 2025-03-19

## TL;DR

This study shows that the loss of a protein called GAP-43 in heart cells disrupts calcium and reactive oxygen species balance, leading to heart disease risks.

## Contribution

The novel contribution is identifying GAP-43's role in regulating Ca2+ and ROS homeostasis in cardiomyocytes, linking its loss to cardiac dysfunction.

## Key findings

- GAP-43−/− cardiomyocytes show increased Ca2+ release and ROS levels.
- Treatment with CaM inhibitor W7 or Ru360 reduces ROS and Ca2+ imbalances.
- Loss of GAP-43 correlates with cardiac hypertrophy and oxidized proteins.

## Abstract

Growth-Associated Protein-43 (GAP-43) is a calmodulin-binding protein, originally found in neurons, that in skeletal muscle regulates the handling of intracellular Ca2+ dynamics. According to its role in Ca2+ regulation, myotubes from GAP-43 knockout (GAP-43−/−) mice display alterations in spontaneous Ca2+ oscillations and increased Ca2+ release. The emerging hypothesis is that GAP-43 regulates CaM interactions with RyR and DHPR Ca2+ channels. The loss of GAP-43 promotes cardiac hypertrophy in newborn GAP-43−/− mice, extending the physiological role of GAP-43 in cardiac muscle. We investigated the role of GAP-43 in cardiomyocytes derived from the hearts of GAP-43−/− mice, evaluating intracellular Ca2+ variations and the correlation with the levels of reactive oxygen species (ROS), considering their importance in cardiovascular physiology. In GAP-43−/− cardiomyocytes, we found the increased expression of markers of cardiac hypertrophy, Ca2+ alterations, and high mitochondria ROS levels (O2•−) together with increased oxidized functional proteins. Treatment with a CaM inhibitor (W7) restored Ca2+ and ROS alterations, possibly due to high mitochondrial Ca2+ entry by a mitochondrial Ca2+ uniporter. Indeed, Ru360 was able to abolish O2•− mitochondrial production. Our results suggest that GAP-43 has a key role in the regulation of Ca2+ and ROS homeostasis, alterations to which could trigger heart disease.

## Linked entities

- **Genes:** GAP43 (growth associated protein 43) [NCBI Gene 2596]
- **Proteins:** CALM1 (calmodulin 1), RYR1 (ryanodine receptor 1), QDPR (quinoid dihydropteridine reductase), CALM1 (calmodulin 1)
- **Chemicals:** W7 (PubChem CID 5681), Ru360 (PubChem CID 171663342), O2•− (PubChem CID 977)
- **Diseases:** heart disease (MONDO:0005267)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ryr1 (ryanodine receptor 1, skeletal muscle) [NCBI Gene 20190] {aka RYR-1, Ryr, skrr}, Gap43 (growth associated protein 43) [NCBI Gene 14432] {aka B-50, Basp2, GAP-43}, Calm2 (calmodulin 2) [NCBI Gene 12314] {aka 1500001E21Rik, Cam2, CamC}, Qdpr (quinoid dihydropteridine reductase) [NCBI Gene 110391] {aka 2610008L04Rik, D5Ertd371e, Dhpr, PKU2}
- **Diseases:** heart disease (MESH:D006331), cardiac hypertrophy (MESH:D006332)
- **Chemicals:** ROS (MESH:D017382), Ru360 (MESH:C112020), W7 (MESH:C017967), Ca2+ (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11939155/full.md

---
Source: https://tomesphere.com/paper/PMC11939155